Is American Cytogenetics Conference Inc Legit?

The American Cytogenetics Conference Inc. demonstrates a fluctuating financial profile, with revenues varying significantly year-to-year, from a low of $9,200 in 2015 to a high of $167,310 in 2014. Despite these fluctuations, the organization has consistently maintained a healthy asset base, growing from $103,221 in 2014 to $193,662 currently, with no reported liabilities across all filings, indicating strong financial solvency. The organization's spending efficiency appears to be generally good, with expenses often aligning closely with revenue, though there are periods of significant surplus (e.g., 2020 with $112,768 revenue and $10,687 expenses) and occasional deficits (e.g., 2022 with $118,013 revenue and $129,583 expenses). The consistent reporting of 0% officer compensation across all filings suggests a volunteer-driven leadership, which contributes positively to spending efficiency and transparency. The organization's consistent filing of IRS Form 990s over 13 periods demonstrates a commitment to transparency.